<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url>
<loc>https://flc.dyphi.com/clinical-archive/2023-ahamscs-exos-ad-intranasal/</loc>
<lastmod>2023-10-20T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/clinical-archive/2024-wj-msc-knee-osteoarthritis-warsaw/</loc>
<lastmod>2024-12-31T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/clinical-archive/2025-laromestrocel-ad-phase2a/</loc>
<lastmod>2025-03-10T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/clinical-archive/2025-wj-msc-spinal-cord-injury/</loc>
<lastmod>2025-06-15T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/clinical-archive/2025-exoflo-ards-phase23/</loc>
<lastmod>2025-09-01T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/en/clinical-archive/2023-ahamscs-exos-ad-intranasal/</loc>
<lastmod>2023-10-20T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/en/clinical-archive/2024-wj-msc-knee-osteoarthritis-warsaw/</loc>
<lastmod>2024-12-31T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/en/clinical-archive/2025-laromestrocel-ad-phase2a/</loc>
<lastmod>2025-03-10T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/en/clinical-archive/2025-wj-msc-spinal-cord-injury/</loc>
<lastmod>2025-06-15T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/en/clinical-archive/2025-exoflo-ards-phase23/</loc>
<lastmod>2025-09-01T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/ru/clinical-archive/2023-ahamscs-exos-ad-intranasal/</loc>
<lastmod>2023-10-20T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/ru/clinical-archive/2024-wj-msc-knee-osteoarthritis-warsaw/</loc>
<lastmod>2024-12-31T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/ru/clinical-archive/2025-laromestrocel-ad-phase2a/</loc>
<lastmod>2025-03-10T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/ru/clinical-archive/2025-wj-msc-spinal-cord-injury/</loc>
<lastmod>2025-06-15T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/ru/clinical-archive/2025-exoflo-ards-phase23/</loc>
<lastmod>2025-09-01T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/stat/2026-03-31-advanced-regenmed-approval-stats/</loc>
<lastmod>2026-03-31T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/en/stat/2026-03-31-advanced-regenmed-approval-stats/</loc>
<lastmod>2026-03-31T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/ru/stat/2026-03-31-advanced-regenmed-approval-stats/</loc>
<lastmod>2026-03-31T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/regenbrief/2026-04-29-exosome-depression/</loc>
<lastmod>2026-04-29T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/regenbrief/2026-04-30-exosome-skin-microneedling/</loc>
<lastmod>2026-04-30T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/regenbrief/2026-04-30-msc-immunogenicity-cell-source/</loc>
<lastmod>2026-04-30T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/en/regenbrief/2026-04-29-exosome-depression/</loc>
<lastmod>2026-04-29T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/en/regenbrief/2026-04-30-exosome-skin-microneedling/</loc>
<lastmod>2026-04-30T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/en/regenbrief/2026-04-30-msc-immunogenicity-cell-source/</loc>
<lastmod>2026-04-30T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/ru/regenbrief/2026-04-29-exosome-depression/</loc>
<lastmod>2026-04-29T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/ru/regenbrief/2026-04-30-exosome-skin-microneedling/</loc>
<lastmod>2026-04-30T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/ru/regenbrief/2026-04-30-msc-immunogenicity-cell-source/</loc>
<lastmod>2026-04-30T00:00:00+00:00</lastmod>
</url>
<url>
<loc>https://flc.dyphi.com/about/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/by-cell-source/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/by-indication/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/by-phase/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/by-region/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/clinical-archive/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/en/about/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/en/clinical-archive/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/en/regenbrief/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/en/stat/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/for-ai/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/en/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/ru/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/stat/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/regenbrief/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/ru/about/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/ru/clinical-archive/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/ru/regenbrief/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/ru/stat/</loc>
</url>
<url>
<loc>https://flc.dyphi.com/AGENTS.html</loc>
</url>
<url>
<loc>https://flc.dyphi.com/skill.html</loc>
</url>
<url>
<loc>https://flc.dyphi.com/naver9165d008c0f43876dde6e5ec8dd99718.html</loc>
<lastmod>2026-05-01T03:00:45+00:00</lastmod>
</url>
</urlset>
